Is NAD+ a Peptide? No — Here's What It Actually Is

Type "NAD" into a search bar and one of the first suggestions is "NAD peptide." Wellness clinics list NAD+ on their peptide menus, peptide vendors sell NAD+ vials alongside actual peptides, and "is NAD a peptide" has become one of the fastest-growing questions in the category. So let's answer it properly.

The short version: no. NAD+ is not a peptide — it's a coenzyme, a completely different kind of molecule. That's not a pedantic technicality; it tells you something useful about how NAD+ works, how it's regulated, and how to evaluate the places selling it. Here's the plain-English chemistry, why the confusion is everywhere, and the questions that matter more than the category.

The chemistry, in two sentences each

A peptide is a short chain of amino acids — the same building blocks as proteins, just fewer of them, linked end to end. Insulin is a peptide; so is semaglutide (GLP-1 stands for glucagon-like peptide-1); so is sermorelin.

NAD+ (nicotinamide adenine dinucleotide) contains no amino-acid chain at all. It's a dinucleotide — two nucleotides joined together, built in part from vitamin B3 — and it works as a coenzyme: a small helper molecule your cells use to shuttle electrons through the reactions that convert food into usable energy. Every living cell in your body depends on it.

Different building blocks, different structure, different job. A peptide is typically a signal — it binds a receptor and tells a cell to do something. NAD+ is machinery — it participates directly in the chemistry of metabolism, cycling between two forms thousands of times a second.

Why everyone thinks NAD+ is a peptide

The mix-up isn't stupid — it's learned. A few forces push the two categories together:

1. Menu adjacency. The clinics and telehealth programs that offer NAD+ tend to be the same ones offering peptide-class treatments, so "NAD" and "peptides" appear side by side on the same pages, over and over.
2. The format. NAD+ is often delivered as a subcutaneous injection from a small vial — visually identical to how peptides are delivered. If it looks like the peptide on the next shelf, people file it there.
3. The conversation. NAD+ and peptides share the same longevity podcasts, the same wellness influencers, and the same search results. Words that travel together get treated as family.

None of that changes the chemistry. It just explains why search engines now see thousands of people asking for a "NAD peptide" that doesn't exist.

Does the category actually matter?

Mostly in one way: regulation. Many of the peptides marketed online — BPC-157, TB-500, and similar — are not FDA-approved and are not on the FDA's list of substances allowed in pharmacy compounding, which is why they're sold as "research use only" vials with no pharmacy involved. That entire problem is specific to those compounds, and NAD+ sits in a different lane: it's available through legitimate channels ranging from dietary supplements to clinician-prescribed compounded preparations. Lumping NAD+ in with "peptides" imports a set of legal problems that don't actually belong to it — and lets vendor sites borrow legitimacy in the other direction.

For the day-to-day decision, though, the category matters less than the pathway. Whatever a clinic calls the thing it's offering, the questions are the same: Is a licensed clinician reviewing your health history and making a real prescribing decision? Is a licensed US pharmacy preparing what you receive? Those two questions separate care from a storefront in every category — peptide, coenzyme, or otherwise. Our state-by-state guide to what's legal and what to avoid walks through exactly that.

What NAD+ actually does — honestly

Two things are well established: NAD+ is essential to cellular energy metabolism, and NAD+ levels tend to decline with age. What raising NAD+ levels does for energy, healthy aging, and other outcomes in healthy adults is an active area of research and is not fully established — a good program talks about NAD+ in terms of what's known, not miracle claims. The full plain-English picture, including the supplements-vs-injection comparison and the honest state of the evidence, is in What is NAD+ therapy?

One adjacent fact worth knowing, since NAD+ shopping usually starts in the supplement aisle: the oral precursor NMN spent years in regulatory limbo, but in 2025 the FDA confirmed it is not excluded from the dietary-supplement definition (it remains a New Dietary Ingredient subject to notification). Supplements and clinician-prescribed preparations remain different things — different oversight, different routes, different conversations.

How Pallas offers NAD+ (and what it's called on the label)

At Pallas, NAD+ is its own clinician-prescribed program — not a "peptide" anything. A US-licensed clinician reviews your intake and, when clinically appropriate, prescribes NAD+ as a subcutaneous injection or nasal spray, prepared by a state-licensed US compounding pharmacy and shipped free. The injection program is $89 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. One all-in price — clinician care, ongoing check-ins, care-team messaging, and your medication when prescribed. Full details at the NAD+ program page.

References

The biology and regulatory points above are drawn from the following sources. NAD+ is a coenzyme, not a GLP-1 medication — no weight-loss claims apply.

1. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119–141.
2. NAD+ precursor supplementation in human ageing: clinical evidence and challenges. Nat Metab. 2025.
3. NutraIngredients-USA. FDA declares NMN lawful in dietary supplements. 2025.

Frequently asked questions